title: Commission Implementing Regulation (EU) 2018/710 of 14 May 2018 renewing the approval of the active substance silthiofam in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance. )

text:
               15.5.2018

               EN

               Official Journal of the European Union

               L 119/31

         COMMISSION IMPLEMENTING REGULATION (EU) 2018/710
   of 14 May 2018
   renewing the approval of the active substance silthiofam in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
   (Text with EEA relevance)
   THE EUROPEAN COMMISSION,
   Having regard to the Treaty on the Functioning of the European Union,
   Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular Article 20(1) thereof,
   Whereas:

               (1)

               Commission Directive 2003/84/EC (2) included silthiofam as an active substance in Annex I to Council Directive 91/414/EEC (3).

               (2)

               Active substances included in Annex I to Directive 91/414/EEC are deemed to have been approved under Regulation (EC) No 1107/2009 and are listed in Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (4).

               (3)

               The approval of the active substance silthiofam, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011, expires on 31 October 2018.

               (4)

               An application for the renewal of the approval of silthiofam was submitted in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 (5) within the time period provided for in that Article.

               (5)

               The applicant submitted the supplementary dossiers required in accordance with Article 6 of Implementing Regulation (EU) No 844/2012. The application was found to be complete by the rapporteur Member State.

               (6)

               The rapporteur Member State prepared a renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the European Food Safety Authority (‘the Authority’) and the Commission on 22 June 2015.

               (7)

               The Authority communicated the renewal assessment report to the applicant and to the Member States for comments and forwarded the comments received to the Commission. The Authority also made the supplementary summary dossier available to the public.

               (8)

               On 1 August 2016 the Authority communicated to the Commission its conclusion (6) on whether silthiofam can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009. The Commission presented the draft renewal report for silthiofam to the Standing Committee on Plants, Animals, Food and Feed on 22 March 2018.

               (9)

               The applicant was given the opportunity to submit comments on the draft renewal report.

               (10)

               It has been established with respect to one or more representative uses of at least one plant protection product containing silthiofam that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied. It is therefore appropriate to renew the approval of silthiofam.

               (11)

               The risk assessment for the renewal of the approval of silthiofam is based on a limited number of representative uses, which however do not restrict the uses for which plant protection products containing silthiofam may be authorised. It is therefore appropriate to remove the restriction for use only as a herbicide.

               (12)

               In accordance with Article 14(1) of Regulation (EC) No 1107/2009 in conjunction with Article 6 thereof and in the light of current scientific and technical knowledge, it is, however, necessary to include certain conditions and restrictions. It is, in particular, appropriate to require further confirmatory information.

               (13)

               The Annex to Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

               (14)

               Commission Implementing Regulation (EU) 2017/1511 (7) extended the approval period of silthiofam to 31 October 2018 in order to allow the renewal process to be completed before the expiry of the approval of that substance. However, given that a decision on renewal has been taken ahead of that extended expiry date, this Regulation should apply from 1 July 2018.

               (15)

               The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

         HAS ADOPTED THIS REGULATION:
   Article 1
   Renewal of the approval of the active substance
   The approval of the active substance silthiofam is renewed as set out in Annex I.
   Article 2
   Amendments to Implementing Regulation (EU) No 540/2011
   The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.
   Article 3
   Entry into force and date of application
   This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
   It shall apply from 1 July 2018.

      This Regulation shall be binding in its entirety and directly applicable in all Member States.
      Done at Brussels, 14 May 2018.

            For the Commission

            The President

         Jean-Claude JUNCKER

      (1)  OJ L 309, 24.11.2009, p. 1.

      (2)  Commission Directive 2003/84/EC of 25 September 2003 amending Council Directive 91/414/EEC to include flurtamone, flufenacet, iodosulfuron, dimethenamid-p, picoxystrobin, fosthiazate and silthiofam as active substances (OJ L 247, 30.9.2003, p. 20).

      (3)  Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market (OJ L 230, 19.8.1991, p. 1).

      (4)  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).

      (5)  Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).

      (6)  EFSA (European Food Safety Authority), 2016. Conclusion on the peer review of the pesticide risk assessment of the active substance silthiofam. EFSA Journal 2016;14(8):4574, 59 pp. doi:10.2903/j.efsa.2016.4574; Available online: www.efsa.europa.eu.

      (7)  Commission Implementing Regulation (EU) 2017/1511 of 30 August 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-methylcyclopropene, beta-cyfluthrin, chlorothalonil, chlorotoluron, cypermethrin, daminozide, deltamethrin, dimethenamid-p, flufenacet, flurtamone, forchlorfenuron, fosthiazate, indoxacarb, iprodione, MCPA, MCPB, silthiofam, thiophanate-methyl and tribenuron (OJ L 224, 31.8.2017, p. 115).

      ANNEX I

                  Common Name, Identification Numbers

                  IUPAC Name

                  Purity (1)

                  Date of approval

                  Expiration of approval

                  Specific provisions

                  Silthiofam
                  CAS No 175217-20-6
                  CIPAC No 635

                  N-allyl-4,5-dimethyl-2-(trimethylsilyl)thiophene-3-carboxamide

                  ≥ 980 g/kg

                  1 July 2018

                  30 June 2033

                  For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on silthiofam and in particular Appendices I and II thereof, shall be taken into account.
                  In their overall assessment Member States shall pay particular attention to:

                              —

                              the protection of operators,

                              —

                              the protection of groundwater in vulnerable regions,

                              —

                              the protection of birds, mammals and earthworms.

                        Conditions of use shall include risk mitigation measures, where appropriate.
                  The applicant shall submit to the Commission, the Member States and the Authority confirmatory information as regards:

                              1.

                              the effect of water treatment processes on the nature of residues present in surface and groundwater, when surface water or groundwater are abstracted for drinking water;

                              2.

                              the relevance of the metabolites M2 and M6 taking into account any relevant classification for silthiofam in accordance with Regulation (EC) No 1272/2008 of the European Parliament and of the Council (2), in particular as reprotoxic category 2.

                        The applicant shall submit the information mentioned in point (1) within two years after a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater is made public by the Commission and the information requested under point (2) within one year after the publication in the European Chemicals Agency (ECHA) webpage of the opinion adopted by the Committee for risk assessment of the ECHA in accordance with Article 37(4) of Regulation (EC) No 1272/2008 with respect to silthiofam.

         (1)  Further details on identity and specification of active substance are provided in the review report.

         (2)  Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (OJ L 353, 31.12.2008, p. 1).

      ANNEX II
      The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

                  (1)

                  in Part A, the entry 70 for Silthiofam is deleted;

                  (2)

                  in Part B, the following entry is added:

                              No

                              Common Name, Identification Numbers

                              IUPAC Name

                              Purity (1)

                              Date of approval

                              Expiration of approval

                              Specific provisions

                              ‘121

                              Silthiofam
                              CAS No 175217-20-6
                              CIPAC No 635

                              N-allyl-4,5-dimethyl-2-(trimethylsilyl)thiophene-3-carboxamide

                              ≥ 980 g/kg

                              1 July 2018

                              30 June 2033

                              For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on silthiofam and in particular Appendices I and II thereof, shall be taken into account.
                              In their overall assessment Member States shall pay particular attention to:

                                          —

                                          the protection of operators,

                                          —

                                          the protection of groundwater in vulnerable regions,

                                          —

                                          the protection of birds, mammals and earthworms.

                                    Conditions of use shall include risk mitigation measures, where appropriate.
                              The applicant shall submit to the Commission, the Member States and the Authority confirmatory information as regards:

                                          1.

                                          the effect of water treatment processes on the nature of residues present in surface and groundwater, when surface water or groundwater are abstracted for drinking water;

                                          2.

                                          the relevance of the metabolites M2 and M6 taking into account any relevant classification for silthiofam in accordance with Regulation (EC) No 1272/2008, in particular as reprotoxic category 2.

                                    The applicant shall submit the information mentioned in point (1) within two years after a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater is made public by the Commission and the information requested under point (2) within one year after the publication in the European Chemicals Agency (ECHA) webpage of the opinion adopted by the Committee for risk assessment of the ECHA in accordance with Article 37(4) of Regulation (EC) No 1272/2008 with respect to silthiofam.’

         (1)  Further details on identity and specification of active substance are provided in the review report.


title: Commission Implementing Regulation (EU) 2018/708 of 17 April 2018 laying down implementing technical standards with regard to the template to be used by managers of money market funds when reporting to competent authorities as stipulated by Article 37 of Regulation (EU) 2017/1131 of the European Parliament and of the Council (Text with EEA relevance. )

text:
                  15.5.2018

                  EN

                  Official Journal of the European Union

                  L 119/5

            COMMISSION IMPLEMENTING REGULATION (EU) 2018/708
      of 17 April 2018
      laying down implementing technical standards with regard to the template to be used by managers of money market funds when reporting to competent authorities as stipulated by Article 37 of Regulation (EU) 2017/1131 of the European Parliament and of the Council
      (Text with EEA relevance)
      THE EUROPEAN COMMISSION,
      Having regard to the Treaty on the Functioning of the European Union,
      Having regard to Regulation (EU) 2017/1131 of the European Parliament and of the Council of 14 June 2017 on money market funds (1), and in particular Article 37(4) thereof,
      Whereas:

                  (1)

                  In addition to the reporting requirements laid down in Directives 2009/65/EC (2) and 2011/61/EU (3) of the European Parliament and of the Council, further reporting requirements are needed to ensure that competent authorities can effectively detect, monitor and respond to risks in the money market funds (MMFs) market.

                  (2)

                  Article 37 of Regulation (EU) 2017/1131 requires MMFs to provide their competent authorities with a detailed list of information. To ensure consistency throughout the European Union in the way these authorities collect such data, and to ensure that the said authorities are informed of the main developments in the MMF market and can facilitate a collective analysis of the potential impacts of the MMF market in the Union, the information needs to be conveyed to the competent authorities in a uniform fashion throughout the EU. Moreover, using a standard reporting template makes it easier to carry out the procedures and processes associated with MMFs' reporting requirements, and minimises the associated costs.

                  (3)

                  To ensure effective supervision within the Union, such data must be forwarded to the European Securities and Markets Authority (ESMA), so that a central database for MMFs is established.

                  (4)

                  This Regulation is based on the draft implementing technical standards submitted by ESMA to the Commission.

                  (5)

                  ESMA has held an open public consultation on the draft implementing technical standards on which this Regulation is based, analysed the potential related costs and benefits, and requested the opinion of the Securities and Markets Stakeholder Group established by Article 37 of Regulation (EU) No 1095/2010 of the European Parliament and of the Council (4).

                  (6)

                  The application date of this Implementing Regulation should be aligned with the date of entry into application of Regulation (EU) 2017/1131 in order to enable the national authorities to collect information to be forwarded to ESMA's data base referred to in Article 37(5) of Regulation (EU) 2017/1131.

            HAS ADOPTED THIS REGULATION:
      Article 1
      Managers of money market funds (MMFs) shall use the template in the Annex to this Regulation when reporting to the competent authority of a particular MMF, as stipulated by Article 37 of Regulation (EU) 2017/1131.
      Article 2
      This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
      It shall apply from 21 July 2018.

         This Regulation shall be binding in its entirety and directly applicable in all Member States.
         Done at Brussels, 17 April 2018.

               For the Commission

               The President

            Jean-Claude JUNCKER

         (1)  OJ L 169, 30.6.2017, p. 8.

         (2)  Directive 2009/65/EC of the European Parliament and of the Council of 13 July 2009 on the coordination of laws, regulations and administrative provisions relating to undertakings for collective investment in transferable securities (UCITS) (recast) (OJ L 302, 17.11.2009, p. 32).

         (3)  Directive 2011/61/EU of the European Parliament and of the Council of 8 June 2011 on Alternative Investment Fund Managers and amending Directives 2003/41/EC and 2009/65/EC and Regulations (EC) No 1060/2009 and (EU) No 1095/2010 (OJ L 174, 1.7.2011, p. 1).

         (4)  Regulation (EU) No 1095/2010 of the European Parliament and of the Council of 24 November 2010 establishing a European Supervisory Authority (European Securities and Markets Authority), amending Decision No 716/2009/EC and repealing Commission Decision 2009/77/EC (OJ L 331, 15.12.2010, p. 84).

         ANNEX

            Reporting template for managers of Money Market Funds (MMFs)

         Except where otherwise specified, all figures shall be filled in at sub-fund level

                     Item

                     Data type

                     Reported data

                                 (A)

                                 APPLICABLE TO ALL MMFS

                                 (1)

                                 General characteristics, identification of the MMF and the manager of that MMF

                     (A.1.1)

                     Reporting period

                     (A.1.2)

                     National code of the MMF as provided by the competent authority of the MMF

                     (A.1.3)

                     LEI of the MMF

                     ISO 17442 Legal Entity Identifier 20 alphanumerical character code (LEI)

                     (A.1.4)

                     ECB code (MFI ID code) of the MMF

                     (A.1.5)

                     Name of the MMF

                     (A.1.6)

                     Indicate if the MMF is a UCITS or an AIF

                     UCITS
                     AIF

                     (A.1.7)

                     Indicate if the MMF is marketed solely through employee saving schemes governed by national law and which have natural persons as investors (in accordance with Art 16(5) of the Regulation (EU) 2017/1131 (1)

                     (Yes/No)

                     (A.1.8)

                     Domicile of the MMF

                     ISO 3166 — Country code

                     (A.1.9)

                     Member State where the MMF is authorised

                     ISO 3166 — Country code

                     (A.1.10)

                     Member States where the MMF is marketed

                     List of Countries (ISO 3166 — Country code)

                     (A.1.11)

                     Inception date of the MMF

                     ISO 8601 date in the format YYYY-MM-DD

                     (A.1.12)

                     Base currency of the MMF

                     ISO 4217 Currency Code, 3 alphabetical characters

                     (A.1.13)

                     National code of the manager of the MMF as provided by the competent authority of the MMF

                     (A.1.14)

                     National code of the manager of the MMF as provided by the competent authority of the manager of the MMF

                     (A.1.15)

                     LEI of the manager of the MMF

                     ISO 17442 LEI 20 alphanumerical character code

                     (A.1.16)

                     ECB code (MFI ID code) of the manager of the MMF

                     (A.1.17)

                     Name of the manager of the MMF

                     (A.1.18)

                     Country where the manager of the MMF is authorized

                     (A.1.19)

                     LEI of the depositary of the MMF

                     ISO 17442 LEI 20 alphanumerical character code

                     (A.1.20)

                     National code of the depositary of the MMF

                     (A.1.21)

                     Legal name of the depositary of the MMF

                                 (2)

                                 Type of the MMF

                     (A.2.1)

                     MMF type [Select one]

                     Short-term VNAV MMF
                     Short-term Public debt CNAV MMF
                     Short-term LVNAV MMF
                     Standard VNAV MMF

                                 (3)

                                 Other characteristics of the MMF

                                 a)

                                    Master/feeder information (MMF marketed solely through employee savings scheme governed by national law and which has natural persons as investors)

                     (A.3.1)

                     If the MMF complies with the conditions of Article 16(5) of Regulation (EU) 2017/1131, indicate whether the MMF is a master or a feeder fund [Select one]

                     Master
                     Feeder

                     If the MMF is a feeder:

                     (A.3.2)

                     LEI of the master of the MMF

                     ISO 17442 LEI 20 alphanumerical character code

                     (A.3.3)

                     National code of the master of the MMF

                     (A.3.4)

                     Legal name of the master of the MMF

                                 b)

                                 Information on share classes

                     (A.3.5)

                     Indicate whether the MMF has share classes

                     (Yes/No)

                     (A.3.6)

                     Where the MMF has share classes, state the single ISIN of the different share classes

                     ISO 6166 ISIN 12 character alphanumerical code

                     (A.3.7)

                     Where the MMF has share classes, state the currency of the different share classes

                     ISO4217 Currency Code, 3 alphabetical characters

                                 c)

                                 Information on preceding fund or liquidation (one-off reporting)

                     If the MMF has been merged with another fund, please indicate:

                     (A.3.8)

                     Date of merger.

                     ISO 8601 date in the format YYYY-MM-DD

                     if the MMF is being liquidated, please indicate:

                     (A.3.9)

                     Date of liquidation.

                     ISO 8601 date in the format YYYY-MM-DD

                                 (4)

                                 Portfolio indicators of the MMF

                                 a)

                                 Total value of assets (for the purpose of the reporting template under the MMF Regulation, it is considered that the total value of assets equals the NAV – please see below field A.4.1)

                                 b)

                                 NAV (subfund level – not share class)

                     (A.4.1)

                     Net asset value of the MMF (subfund level)

                     (EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.4.2)

                     Net asset value of the MMF

                     (in base currency)

                                 c)

                                 WAM

                     (A.4.3)

                     Weighted Average Maturity of the MMF calculated as set out in Article 2(19) of Regulation (EU) 2017/1131.

                     (days)

                                 d)

                                 WAL

                     (A.4.4)

                     Weighted Average Life of the MMF calculated as set out in Articles 2(20), 24(1)(b), 25(1)(b) of Regulation (EU) 2017/1131.

                     (days)

                                 e)

                                 Liquidity indicators

                        Portfolio Liquidity Profile

                     (A.4.5)

                     % of assets qualifying for the daily liquidity buffer (daily maturing assets as defined under Articles 24 and 25 of Regulation (EU) 2017/1131)

                     %

                     (A.4.6)

                     % of assets qualifying for the weekly liquidity buffer (weekly maturing assets as defined under Articles 24 and 25 of Regulation (EU) 2017/1131)

                     %

                     (A.4.7)

                     Portfolio liquidity profile

                     Percentage of portfolio capable of being liquidated that fall within each period

                     Period

                                       1 day or less

                                       2-7 days

                                       8-30 days

                                       above 30 days

                                 f)

                                 Yield

                     (A.4.8)

                     Cumulative returns

                     %

                     Range

                                       YTD

                                       1 month

                                       3 months

                                       1 year

                                       3 years

                                       5 years

                     (A.4.9)

                     Calendar year performance (net return) of the most representative share class

                     %

                     Range

                                       Year N-1

                                       Year N-2

                                       Year N-3

                     (A.4.10)

                     Monthly portfolio volatility and Monthly portfolio volatility of the shadow NAV (when applicable)

                     %

                     Range

                                       1 year

                                       2 years

                                       3 years

                                 (5)

                                 Stress tests of the MMF

                                 a)

                                 Results of the stress tests of the MMF

                     (A.5.1)

                     Results of the liquidity stress tests of the MMF conducted within the reporting period as set out in Art 28(1) of Regulation (EU) 2017/1131 and the corresponding ESMA guidelines on stress tests scenarios

                     (A.5.2)

                     Results of the credit stress tests of the MMF conducted within the reporting period as set out in Art 28(1) of Regulation (EU) 2017/1131 and the corresponding ESMA guidelines on stress tests scenarios

                     (A.5.3)

                     Results of the FX rate stress tests of the MMF conducted within the reporting period as set out in Art 28(1) of Regulation (EU) 2017/1131 and the corresponding ESMA guidelines on stress tests scenarios

                     (A.5.4)

                     Results of the Interest rate stress tests of the MMF conducted within the reporting period as set out in Art 28(1) of Regulation (EU) 2017/1131 and the corresponding ESMA guidelines on stress tests scenarios

                     (A.5.5)

                     Results of stress test on the level of redemption of the MMF conducted within the reporting period as set out in Art 28(1) of Regulation (EU) 2017/1131 and the corresponding ESMA guidelines on stress tests scenarios

                     (A.5.6)

                     Results of stress test of the MMF on the spread among indices to which interest rate of portfolio securities are tied conducted within the reporting period as set out in Art 28(1) of Regulation (EU) 2017/1131 and the corresponding ESMA guidelines on stress tests scenarios

                     (A.5.7)

                     Results of the macro stress test of the MMF conducted within the reporting period as set out in Art 28(1) of Regulation (EU) 2017/1131 and the corresponding ESMA guidelines on stress tests scenarios

                     (A.5.8)

                     Results of the multivariate stress test of the MMF conducted within the reporting period as set out in Art 28(1) of Regulation (EU) 2017/1131 and the corresponding ESMA guidelines on stress tests scenarios

                     (A.5.9)

                     In the case of CNAV and LVNAV MMFs, indicate the results of the stress tests mentioned in the fields A.5.1 to A.5.8 in terms of difference between the constant NAV per unit or share and the NAV per unit or share

                                 b)

                                 Proposed action plan (where applicable)

                     (A.5.10)

                     Indicate the proposed action plan as set out in Art 28(4) of Regulation (EU) 2017/1131

                     Free text

                                 (6)

                                 Information on the assets held in the portfolio of the MMF

                                 a)

                                 Money market instruments, eligible securitisations and asset backed commercial papers

                        The below fields A.6 shall be completed using a line-by-line reporting template

                     (A.6.1)

                     Type of the Money market instrument, eligible securitisations and asset backed commercial papers [Select one or several]

                     Indicate the type of money market instruments, eligible securitisations and asset backed commercial papers

                     Money market instruments under Article 10 of Regulation (EU) 2017/1131
                     Securitisations referred to in Article 13 of Commission Delegated Regulation (EU) 2015/61 (2)

                     ABCPs as referred to in Art 11(1)(b) of Regulation (EU) 2017/1131
                     A simple, transparent and standardised securitisation or ABCP as referred to in Art 11(1)(c) of Regulation (EU) 2017/1131

                        If the type of asset is a money market instrument, complete the fields A.6.2 to A.6.20

                     (A.6.2)

                     Asset description of the money market instrument

                     (A.6.3)

                     ISIN of the money market instrument

                     ISO 6166 ISIN 12 character alphanumerical code

                     (A.6.4)

                     CFI (if available, and if the ISIN is not available) of the money market instrument

                     ISO 10692 CFI, 6 characters alphabetical code

                     (A.6.5)

                     LEI of the issuer

                     ISO 17442 LEI 20 alphanumerical character code

                     (A.6.6)

                     Name of the issuer

                     (A.6.7)

                     Issuer category
                     The issuer categories shall be selected among the corresponding ones [Select one]

                     Sovereign (EU)
                     Sovereign (non-EU)
                     EU Central Bank
                     Non EU Central Bank
                     Regional
                     Local
                     National Public body
                     EU Public body (except National Public body)
                     Non EU Public body
                     Supranational Public body (EU)
                     Supranational Public body (other than EU)
                     Credit institution
                     Other financial corporations
                     Non-financial corporations

                     (A.6.8)

                     Country of the issuer of the money market instrument

                     ISO 3166 — Country code

                     (A.6.9)

                     Maturity date of the money market instrument

                     ISO 8601 date in the format YYYY-MM-DD

                     (A.6.10)

                     Currency of the money market instrument

                     (ISO 4217 Currency Code, 3 alphabetical characters)

                     (A.6.11)

                     Quantity of the money market instrument

                     (A.6.12)

                     Clean price of the money market instrument

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.6.13)

                     Clean Price of the money market instrument

                     (in base currency)

                     (A.6.14)

                     Accrued interests

                     (A.6.15)

                     Accrued interests

                     (in base currency, if A.6.14 is in EUR)

                     (A.6.16)

                     Total market value of the money market instrument

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.6.17)

                     Total market value of the money market instrument

                     (in base currency)

                     (A.6.18)

                     Method used to price the money market instrument

                     mark to market
                     mark-to-model
                     amortised cost

                     (A.6.19)

                     Indicate whether the outcome of the internal credit assessment procedure is favourable or unfavourable

                     (favourable/unfavourable)

                     (A.6.20)

                     Provide the next interest rate reset date (as mentioned in Art 10(2) of Regulation (EU) 2017/1131)

                     ISO 8601 date in the format YYYY-MM-DD

                        If the type of asset is an eligible securitisation or asset backed commercial paper, complete the fields A.6.21 to A.6.37

                     (A.6.21)

                     Asset description of the eligible securitisation or asset backed commercial paper

                     (A.6.22)

                     ISIN of the eligible securitisation or asset backed commercial paper

                     ISO 6166 ISIN 12 character alphanumerical code

                     (A.6.23)

                     Country of the sponsor of the eligible securitisation and asset backed commercial paper

                     ISO 3166 — Country code

                     (A.6.24)

                     LEI of the sponsor

                     ISO 17442 LEI 20 alphanumerical character code

                     (A.6.25)

                     Name of the sponsor

                     (A.6.26)

                     The type of underlying

                     Trade receivables
                     Consumer loans
                     Leasing
                     Credit card receivables
                     Loans to corporates or SME
                     Residential Mortgage
                     Commercial Mortgage
                     Other assets

                     (A.6.27)

                     Maturity date

                     ISO 8601 date in the format YYYY-MM-DD

                     (A.6.28)

                     Currency

                     (ISO 4217 Currency Code, 3 alphabetical characters)

                     (A.6.29)

                     Quantity

                     (A.6.30)

                     Clean price

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.6.31)

                     Clean Price

                     (in base currency)

                     (A.6.32)

                     Accrued interests

                     (A.6.33)

                     Accrued interests

                     (in base currency, if A.6.30 is in EUR)

                     (A.6.34)

                     Total market value

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.6.35)

                     Total market value

                     (in base currency)

                     (A.6.36)

                     Method used to price the eligible securitisations or asset backed commercial paper

                     mark to market
                     mark-to-model
                     amortised cost

                     (A.6.37)

                     Whether the outcome of the internal credit assessment procedure is favourable/unfavourable

                     (favourable/unfavourable)

                                 b)

                                 Other assets

                     (A.6.38)

                     Type of the Other assets [Select one]
                     The type of other assets shall be selected among the assets listed in Article 9 of Regulation (EU) 2017/1131

                     Deposits with credit institutions as referred to in Article 12 of Regulation (EU) 2017/1131
                     Reverse repurchase agreements as referred to in Article 15 of Regulation (EU) 2017/1131
                     Repurchase agreements as referred to in Article 14 of Regulation (EU) 2017/1131
                     Units or shares of other MMFs as referred to in Article 16 of Regulation (EU) 2017/1131
                     Financial derivative instruments as referred to in Article 13 of Regulation (EU) 2017/1131 of which:

                                 —

                                 Financial derivative instruments dealt in on a regulated market (and specify if it falls under Article 50(1)(a), (b) or (c) of Directive 2009/65/EC)

                                 —

                                 Financial derivative instruments dealt over-the-counter

                           Ancillary liquid assets (in accordance with Article 50(2) of Directive 2009/65/EC)

                        If the type of other asset is a financial derivative instrument, complete the fields A.6.39 to A.6.60

                     (A.6.39)

                     Contract type of derivative contract

                     (A.6.40)

                     ISIN of the financial derivative instrument

                     ISO 6166 ISIN 12 character alphanumerical code

                     (A.6.41)

                     UPI of the financial derivative instrument (if the ISIN is not available)

                     (A.6.42)

                     FISN (Financial Instrument Short Name) of the financial derivative instrument

                     ISO 18774

                     (A.6.43)

                     CFI code (if available and if the ISIN is not available) of the financial derivative instrument

                     ISO 10692 CFI, 6 characters alphabetical code

                     (A.6.44)

                     Type of derivative instrument set out in Article 13(a) of Regulation (EU) 2017/1131 [select one]

                     interest rate
                     currencies
                     indices of interest rates
                     indices of currencies

                     (A.6.45)

                     Name of the underlying

                     (A.6.46)

                     Underlying identification type (3)

                     I = ISIN
                     X = Index

                     (A.6.47)

                     Underlying identification

                     For underlying identification type I: ISO 6166 ISIN 12 character alphanumerical code
                     For underlying identification type X: ISO 6166 ISIN 12 character alphanumerical code if available, otherwise full name of the index as assigned by the index provider

                     (A.6.48)

                     Notional currency 1 (4)

                     ISO 4217 Currency Code

                     (A.6.49)

                     Notional currency 2 (5)

                     ISO 4217 Currency Code

                     (A.6.50)

                     Country of the financial derivative instrument

                     ISO 3166 — Country code

                     (A.6.51)

                     Maturity date of the financial derivative instrument

                     ISO 8601 date in the format YYYY-MM-DD

                     (A.6.52)

                     Exposure of the financial derivative instrument

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.6.53)

                     Exposure of the financial derivative instrument

                     (in base currency)

                     (A.6.54)

                     Market value of the financial derivative instrument

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.6.55)

                     Market value of the financial derivative instrument

                     (in base currency)

                     (A.6.56)

                     Market value of the collateral received (in relation to the financial derivative instrument)

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.6.57)

                     Market value of the collateral received (in relation to the financial derivative instrument)

                     (in base currency)

                     (A.6.58)

                     Provide the next interest rate reset date (as mentioned in Art 10(2) of Regulation (EU) 2017/1131)

                     ISO 8601 date in the format YYYY-MM-DD

                     (A.6.59)

                     Name of the Counterparty

                     (A.6.60)

                     LEI of the Counterparty

                     ISO 17442 LEI 20 alphanumerical character code

                        If the type of other asset is a unit or share of other MMF, complete the fields A.6.61 to A.6.71

                     (A.6.61)

                     Asset description of the unit or share of other MMF

                     (A.6.62)

                     ISIN of the unit or share of other MMF

                     ISO 6166 ISIN 12 character alphanumerical code

                     (A.6.63)

                     LEI (if the ISIN is not available) of the unit or share of other MMF

                     (A.6.64)

                     CFI code (if available and if the ISIN is not available) of the unit or share of other MMF

                     ISO 10692 CFI, 6 characters alphabetical code

                     (A.6.65)

                     Currency

                     (ISO 4217 Currency Code, 3 alphabetical characters)

                     (A.6.66)

                     Country of the unit or share of other MMF

                     ISO 3166 — Country code

                     (A.6.67)

                     Market value of the unit or share of other MMF

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.6.68)

                     Market value of unit or share of other MMF

                     (in base currency)

                     (A.6.69)

                     Quantity

                     (A.6.70)

                     Price of the unit or share of other MMF (NAV per unit or share of other MMF)

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.6.71)

                     Price of the unit or share of other MMF (NAV per unit or share of other MMF)

                     (in base currency)

                        If the type of other asset is a deposit or ancillary liquid assets, complete the fields A.6.72 to A.6.81

                     (A.6.72)

                     Asset description of the deposit or ancillary liquid assets

                     (A.6.73)

                     ISIN of the deposit or ancillary liquid assets

                     ISO 6166 ISIN 12 character alphanumerical code

                     (A.6.74)

                     CFI (if available and if the ISIN is not available) of the deposit or ancillary liquid assets

                     ISO 10692 CFI, 6 characters alphabetical code

                     (A.6.75)

                     Country of the deposit or ancillary liquid assets

                     ISO 3166 — Country code

                     (A.6.76)

                     Name of the counterparty

                     (A.6.77)

                     LEI of the counterparty

                     ISO 17442 LEI 20 alphanumerical character code

                     (A.6.78)

                     Maturity date of the deposit or ancillary liquid assets

                     ISO 8601 date in the format YYYY-MM-DD

                     (A.6.79)

                     Currency

                     (ISO 4217 Currency Code, 3 alphabetical characters)

                     (A.6.80)

                     Exposure of the deposit or ancillary liquid assets

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.6.81)

                     Exposure of the deposit or ancillary liquid assets

                     (in base currency)

                        If the type of other asset is a repurchase agreement or a reverse repurchase agreement assets, complete the fields A.6.82 to A.6.99

                     (A.6.82)

                     Asset description of the repurchase agreement or a reverse repurchase agreement

                     (A.6.83)

                     ISIN of the repurchase agreement or a reverse repurchase agreement

                     ISO 6166 ISIN 12 character alphanumerical code

                     (A.6.84)

                     CFI (if available and if the ISIN is not available) of the repurchase agreement or a reverse repurchase agreement

                     ISO 10692 CFI, 6 characters alphabetical code

                     (A.6.85)

                     Country of the repurchase agreement or a reverse repurchase agreement

                     ISO 3166 — Country code

                     (A.6.86)

                     Counterparty category
                     The counterparty category shall be selected among the following ones (please see Art 20(2)(e) of Regulation (EU) 2017/1131) [Select one]

                     Sovereign (EU)
                     Sovereign (non-EU)
                     EU Central Bank
                     Non EU Central Bank
                     Regional
                     Local
                     National Public body
                     EU Public body (except National Public body)
                     Non-EU Public body
                     Supranational Public body (EU)
                     Supranational Public body (other than EU)
                     Credit institution
                     Other financial corporations
                     Non-financial corporations

                     (A.6.87)

                     LEI of the counterparty

                     ISO 17442 LEI 20 alphanumerical character code

                     (A.6.88)

                     Name of the counterparty

                     (A.6.89)

                     Maturity date of the repurchase agreement or a reverse repurchase agreement

                     ISO 8601 date in the format YYYY-MM-DD

                     (A.6.90)

                     Currency

                     (ISO 4217 Currency Code, 3 alphabetical characters)

                     (A.6.91)

                     Exposure of the repurchase agreement or a reverse repurchase agreement (in the case of reverse repurchase agreement, this is the amount of cash provided to the counterparty)

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.6.92)

                     Exposure of the repurchase agreement or a reverse repurchase agreement (in the case of reverse repurchase agreement, this is the amount of cash provided to the counterparty)

                     (in base currency)

                     (A.6.93)

                     Market value of the collateral received (in relation to the repurchase agreement or a reverse repurchase agreement) (the amount of cash received by the MMF as part of repurchase agreements (as referred to in Article 14(d) of Regulation (EU) 2017/1131)

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.6.94)

                     Market value of the collateral received (in relation to the repurchase agreement or a reverse repurchase agreement) (the amount of cash received by the MMF as part of repurchase agreements (as referred to in Art 14(d) of Regulation (EU) 2017/1131)

                     (in base currency)

                     (A.6.95)

                     Whether the outcome of the internal credit assessment procedure is favourable or unfavourable (for the different liquid transferable securities or (other) money market instruments received as part of a reverse repurchase agreement as referred to in Article 15(6) of Regulation (EU) 2017/1131) (6)

                     (favourable/unfavourable)

                     In the context of the reverse repurchase agreements and assets referred to in Article 15 of Regulation (EU) 2017/1131 that were received by the MMF, please indicate:

                     (A.6.96)

                     ISIN of these different assets

                     ISO 6166 ISIN 12 character alphanumerical code

                     (A.6.97)

                     Market value of these different assets

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (A.6.98)

                     Market value of these different assets

                     (in base currency)

                     (A.6.99)

                     In the context of the reverse repurchase agreements, whether there are any assets as referred to in Article 15(6) of Regulation (EU) 2017/1131 that were received by the MMF

                     (Yes/No)

                                 (7)

                                 Information on the liabilities of the MMF

                                 a)

                                 information on the investors – investor concentration

                     (A.7.1)

                     Specify the approximate percentage of the MMF's equity that is beneficially owned by the five beneficial owners that have the largest equity interest in the MMF, as a percentage of NAV of the MMF. Look-through to the ultimate beneficial owners where known or possible

                     % (of NAV)

                                 b)

                                 information on the investors – breakdown of investor concentration

                     (A.7.2)

                     Specify the breakdown of investor concentration by status of investors (estimate if no precise information available): 1) Professional clients (as defined in Article 4(1)(10) of Directive 2014/65/EU of the European Parliament and of the Council (7) (MiFID 2)) 2) retail clients (as defined in Article 4(1)(11) of Directive 2014/65/EU (MiFID 2))

                                 —

                                 Professional clients (as defined in in Article 4(1)(10) of Directive 2014/65/EU (MiFID 2))

                     % (of NAV)

                                 —

                                 Retail clients (as defined in Article 4(1)(11) of Directive 2014/65/EU (MiFID 2))

                     % (of NAV)

                                 c)

                                 information on the investors – geographical breakdown

                     (A.7.3)

                     Provide the breakdown of the ownership of units/shares in the MMF by investor group. Look-through to the ultimate beneficial owners where known or possible.

                     (% of NAV)
                     Non-financial corporations
                     Banks
                     Insurance corporations
                     Other financial institutions
                     Pension plans/funds
                     General government
                     Other collective investment undertakings
                     Households
                     Unknown

                     (A.7.4)

                     Specify the geographical breakdown of investors by country (estimate if no precise information available)

                     Country

                     (% of NAV, Country — ISO 3166 — 2 character)

                                 d)

                                 Information on investors — subscription and redemption activity

                        Investor redemptions

                     (A.7.5)

                     State the frequency of investor redemptions. If multiple classes of shares or units, report for the largest share or unit class by NAV. [Select one]

                     Daily
                     Weekly
                     Monthly
                     Bimonthly
                     Other
                     No redemption rights

                     (A.7.6)

                     What is the notice period required by investors for redemptions in days

                     Days

                     (A.7.7)

                     As at the reporting date, what percentage of the MMFs NAV is subject to the following arrangements:

                     Gates

                     % of NAV

                     Suspension of dealing

                     % of NAV

                     Liquidity fees

                     % of NAV

                     Other arrangements for managing illiquid assets

                     Type of arrangement

                     % of NAV

                     (A.7.8)

                     Net Asset Value of the MMF over the reporting period

                     (in EUR, including the impact of subscriptions and redemptions) (at the last day of the month)

                     January

                     February

                     March

                     April

                     May

                     June

                     July

                     August

                     September

                     October

                     November

                     December

                     (A.7.9)

                     Subscriptions over the reporting period

                     (in EUR)

                     January

                     February

                     March

                     April

                     May

                     June

                     July

                     August

                     September

                     October

                     November

                     December

                     (A.7.10)

                     Redemptions over the reported period

                     (in EUR)

                     January

                     February

                     March

                     April

                     May

                     June

                     July

                     August

                     September

                     October

                     November

                     December

                     (A.7.11)

                     Payments to investors

                     (in EUR)

                     January

                     February

                     March

                     April

                     May

                     June

                     July

                     August

                     September

                     October

                     November

                     December

                     (A.7.12)

                     Exchange rate

                     January

                     February

                     March

                     April

                     May

                     June

                     July

                     August

                     September

                     October

                     November

                     December

            LVNAV MMFs

                     Item

                     Data type

                     Reported data

                                 (B)

                                 APPLICABLE TO LVNAV MMF

                                 a)

                                 Indicate every event in which the price of an asset valued by using the amortised cost method in accordance with the first subparagraph of Article 29(7) of Regulation (EU) 2017/1131 deviates from the price of that asset calculated in accordance with paragraphs 2, 3 and 4 of Article 29 of Regulation (EU) 2017/1131 by more than 10 basis points. These fields should be reported for every asset the price of which, by using the amortised cost method, would deviate in such a way.

                     (B.1.1)

                     Valuation date (the first day where the event occurs)

                     ISO 8601 date in the format YYYY-MM-DD

                     (B.1.2)

                     ISIN of the asset

                     ISO 6166 ISIN 12 character alphanumerical code

                     (B.1.3)

                     CFI code (if available and if the ISIN is not available) of the asset

                     ISO 10692 CFI, 6 characters alphabetical code

                     (B.1.4)

                     Price (paragraphs 2, 3 and 4 of Article 29 of Regulation (EU) 2017/1131) (at the valuation date mentioned in field B.1.1. when the event occurs)

                     (B.1.5)

                     Price (amortised cost method) (at the valuation date mentioned in field B.1.1. when the event occurs)

                     (B.1.6)

                     From the valuation date specified in field B.1.1, state how long the price of an asset valued by using the amortised cost method deviated by more than 10 basis points from the price of that asset

                     (days)

                     (B.1.7)

                     During the period mentioned in field B.1.6, state the average difference between the two values mentioned in field B.1.6

                     (B.1.8)

                     During the period mentioned in field B.1.6., state the minimum price deviation between the two values

                     (B.1.9)

                     During the period mentioned in field B.1.6, state the maximum price deviation between the two values

                                 b)

                                 Indicate every event in which the constant NAV per unit or share calculated in accordance with paragraphs 1 and 2 of Article 32 of Regulation (EU) 2017/1131 deviates from the NAV per unit or share calculated in accordance with Article 30 of Regulation (EU) 2017/1131 by more than 20 basis points.

                     (B.1.10)

                     Valuation date (the first day the event occurs)

                     ISO 8601 date in the format YYYY-MM-DD

                     (B.1.11)

                     Constant NAV (Article 31 of Regulation (EU) 2017/1131) (at the valuation date mentioned in field B.1.10, when the event occurs)

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (B.1.12)

                     Constant NAV (Article 31 of Regulation (EU) 2017/1131) (at the valuation date mentioned in field B.1.10, when the event occurs)

                     (in base currency)

                     (B.1.13)

                     NAV (Article 30 of Regulation (EU) 2017/1131) (at the valuation date mentioned in field B.1.10, when the event occurs)

                     (in EUR) (if the base currency is not in EUR the exchange ratio used shall be the rate most recently set by the European Central Bank)

                     (B.1.14)

                     NAV (Article 30 of Regulation (EU) 2017/1131) (at the valuation date mentioned in field B.1.10, when the event occurs)

                     (in base currency)

                     (B.1.15)

                     From the valuation date specified in field B.1.10, state how long did the constant NAV per unit or share calculated deviate from the NAV per unit or share calculated by more than 20 basis points

                     (days)

                     (B.1.16)

                     During the period mentioned in field B.1.15, state the average difference between the two values mentioned on field B.1.15

                     (B.1.17)

                     During the period mentioned in field B.1.15, state the minimum price deviation between the two values

                     (B.1.18)

                     During the period mentioned in field B.1.15, state the maximum price deviation between the two values

                                 c)

                                 Indicate every event in which a situation mentioned in Article 34(3) of Regulation (EU) 2017/1131 occurs and the measures taken by the board in accordance with points (a) and (b) of Article 34(1) of that Regulation.

                     (B.1.19)

                     Date of the event

                     ISO 8601 date in the format YYYY-MM-DD

                     (B.1.20)

                     Date when the measure was taken

                     ISO 8601 date in the format YYYY-MM-DD

                     (B.1.21)

                     Type of measure (Whenever the proportion of weekly maturing assets falls below 30 % of the total assets of the MMF and whenever the net daily redemptions on a single business day exceed 10 % of total assets)

                     liquidity fees on redemptions
                     redemption gates
                     suspension of redemptions
                     take no immediate action other than correcting the situation where limits referred to in Article 24(1) of Regulation (EU) 2017/1131 are exceeded, in accordance with Article 24(2) of that Regulation

                     (B.1.22)

                     Type of measure (Whenever the proportion of weekly maturing assets falls below 10 % of its total assets)

                     liquidity fees on redemptions
                     suspension of redemptions

            (1)  Regulation (EU) 2017/1131 of the European Parliament and of the Council of 14 June 2017 on money market funds

            (2)  Commission Delegated Regulation (EU) 2015/61 of 10 October 2014 to supplement Regulation (EU) No 575/2013 of the European Parliament and the Council with regard to liquidity coverage requirement for Credit Institutions (OJ L 11, 17.1.2015, p. 1).

            (3)  Financial derivative identification in EMIR

            (4)  The currency of the notional amount. In the case of an interest rate derivative contract, this will be the notional currency of leg 1.

            (5)  The currency of the notional amount. In the case of an interest rate derivative contract, this will be the notional currency of leg 2.

            (6)  If the MMF receives as collateral different assets within the meaning of Article 15(6) of Regulation (EU) 2017/1131, the outcome should be reported for each asset.

            (7)  Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU


title: Council Implementing Regulation (EU) 2018/714 of 14 May 2018 implementing Regulation (EU) 2017/1509 concerning restrictive measures against the Democratic People's Republic of Korea

text:
               16.5.2018

               EN

               Official Journal of the European Union

               L 120/1

         COUNCIL IMPLEMENTING REGULATION (EU) 2018/714
   of 14 May 2018
   implementing Regulation (EU) 2017/1509 concerning restrictive measures against the Democratic People's Republic of Korea
   THE COUNCIL OF THE EUROPEAN UNION,
   Having regard to the Treaty on the Functioning of the European Union,
   Having regard to Council Regulation (EU) 2017/1509 of 30 August 2017 concerning restrictive measures against the Democratic People's Republic of Korea and repealing Regulation (EC) No 329/2007 (1), and in particular Article 47(2) thereof,
   Having regard to the proposal from the High Representative of the Union for Foreign Affairs and Security Policy,
   Whereas:

               (1)

               On 30 August 2017, the Council adopted Regulation (EU) 2017/1509.

               (2)

               On 14 May 2018 the Council adopted Decision (CFSP) 2018/715 (2), which moved six persons to Annex III to Decision (CFSP) 2016/849 and removed them from Annex II thereto.

               (3)

               Annex XVI and Annex XV to Regulation (EU) 2017/1509 should therefore be amended accordingly,

         HAS ADOPTED THIS REGULATION:
   Article 1
   Annex XVI and Annex XV to Regulation (EU) 2017/1509 are amended as set out in the Annex to this Regulation.
   Article 2
   This Regulation shall enter into force on the day of its publication in the Official Journal of the European Union.

      This Regulation shall be binding in its entirety and directly applicable in all Member States.
      Done at Brussels, 14 May 2018.

            For the Council

            The President

         E. ZAHARIEVA

      (1)  OJ L 224, 31.8.2017, p. 1.

      (2)  Council Decision (CFSP) 2018/715 of 14 May 2018 amending Decision (CFSP) 2016/849 concerning restrictive measures against the Democratic People's Republic of Korea (see page 4 of this Official Journal).

      ANNEX

                  A.

                  In Annex XVI to Regulation (EU) 2017/1509, under the heading ‘(a) Natural persons’, the following entries are added:

                              Name (and possible aliases)

                              Identifying information

                              Date of designation

                              Reasons

                              ‘19.

                              KIM Il-Su
                              a.k.a. KIM Il Su

                              DOB: 2.9.1965
                              POB: Pyongyang, DPRK

                              3.7.2015

                              Manager in the reinsurance department of the Korea National Insurance Corporation (KNIC) based in the headquarters in Pyongyang and former authorised chief representative of KNIC in Hamburg, acting on behalf of KNIC or at its direction.

                              20.

                              KANG Song-Sam
                              a.k.a. KANG Song Sam

                              DOB: 5.7.1972
                              POB: Pyongyang, DPRK

                              3.7.2015

                              Former authorised representative of the Korea National Insurance Corporation (KNIC) in Hamburg, continues to act for or on behalf of KNIC or at its direction.

                              21.

                              CHOE Chun-Sik
                              a.k.a. CHOE Chun Sik

                              DOB: 23.12.1963
                              POB: Pyongyang, DPRK
                              Passport number: 745132109
                              Valid until 12.2.2020

                              3.7.2015

                              Director in the reinsurance department of the Korea National Insurance Corporation (KNIC) based in the headquarters in Pyongyang acting on behalf of KNIC or at its direction.

                              22.

                              SIN Kyu-Nam
                              a.k.a. SIN Kyu Nam

                              DOB: 12.9.1972
                              POB: Pyongyang, DPRK
                              Passport number: PO472132950

                              3.7.2015

                              Director in the reinsurance department of the Korea National Insurance Corporation (KNIC) based in the headquarters in Pyongyang and former authorised representative of KNIC in Hamburg, acting on behalf of KNIC or at its direction.

                              23.

                              PAK Chun-San
                              a.k.a. PAK Chun San

                              DOB: 18.12.1953
                              POB: Pyongyang, DPRK
                              Passport number: PS472220097

                              3.7.2015

                              Director in the reinsurance department of the Korea National Insurance Corporation (KNIC) based in the headquarters in Pyongyang at least until December 2015 and former authorised chief representative of KNIC in Hamburg, continues to act for or on behalf of KNIC or at its direction.

                              24.

                              SO Tong Myong

                              DOB: 10.9.1956

                              3.7.2015

                              President of the Korea National Insurance Corporation (KNIC), KNIC Executive Management Committee Chairman (June 2012); Korean National Insurance Corporation General Manager, September 2013, acting on behalf of KNIC or at its direction.’

                  B.

                  In Annex XV to Regulation (EU) 2017/1509, under the heading ‘(c) Natural persons designated in accordance with point (b) of Article 34(4)’, the following entries are removed:

                              Name (and possible aliases)

                              Identifying information

                              Date of designation

                              Reasons

                              ‘3.

                              KIM Il-Su
                              (alias KIM Il Su)

                              DOB: 2.9.1965
                              POB: Pyongyang, DPRK

                              3.7.2015

                              Manager in the reinsurance department of the Korea National Insurance Corporation (KNIC) based in the headquarters in Pyongyang and former authorised chief representative of KNIC in Hamburg, acting on behalf of KNIC or at its direction.

                              4.

                              KANG Song-Sam
                              (alias KANG Song Sam)

                              DOB: 5.7.1972
                              POB: Pyongyang, DPRK

                              3.7.2015

                              Former authorised representative of the Korea National Insurance Corporation (KNIC) in Hamburg, continues to act for or on behalf of KNIC or at its direction.

                              5.

                              CHOE Chun-Sik
                              (alias CHOE Chun Sik)

                              DOB: 23.12.1963
                              POB: Pyongyang, DPRK
                              Passport 745132109
                              Valid until 12.2.2020

                              3.7.2015

                              Director in the reinsurance department of the Korea National Insurance Corporation (KNIC) based in the headquarters in Pyongyang acting on behalf of KNIC or at its direction.

                              6.

                              SIN Kyu-Nam
                              (alias SIN Kyu Nam)

                              DOB: 12.9.1972
                              POB: Pyongyang, DPRK
                              Passport PO472132950

                              3.7.2015

                              Director in the reinsurance department of the Korea National Insurance Corporation (KNIC) based in the headquarters in Pyongyang and former authorised representative of KNIC in Hamburg, acting on behalf of KNIC or at its direction.

                              7.

                              PAK Chun-San
                              (alias PAK Chun San)

                              DOB: 18.12.1953
                              POB: Pyongyang, DPRK
                              Passport PS472220097

                              3.7.2015

                              Director in the reinsurance department of the Korea National Insurance Corporation (KNIC) based in the headquarters in Pyongyang at least until December 2015 and former authorised chief representative of KNIC in Hamburg, continues to act for or on behalf of KNIC or at its direction.

                              8.

                              SO Tong Myong

                              DOB: 10.9.1956

                              3.7.2015

                              President of the Korea National Insurance Corporation (KNIC), KNIC Executive Management Committee Chairman (June 2012); Korean National Insurance Corporation General Manager, September 2013, acting on behalf of KNIC or at its direction.’


title: Commission Implementing Regulation (EU) 2018/723 of 16 May 2018 amending Annexes I and II to Council Regulation (EC) No 1099/2009 on the protection of animals at the time of killing as regards the approval of low atmospheric pressure stunning (Text with EEA relevance. )

text:
               17.5.2018

               EN

               Official Journal of the European Union

               L 122/11

         COMMISSION IMPLEMENTING REGULATION (EU) 2018/723
   of 16 May 2018
   amending Annexes I and II to Council Regulation (EC) No 1099/2009 on the protection of animals at the time of killing as regards the approval of low atmospheric pressure stunning
   (Text with EEA relevance)
   THE EUROPEAN COMMISSION,
   Having regard to the Treaty on the Functioning of the European Union,
   Having regard to Council Regulation (EC) No 1099/2009 of 24 September 2009 on the protection of animals at the time of killing (1), and in particular Article 4(2) and point (b) of the first subparagraph of Article 14(3) thereof,
   After consulting the Standing Committee on Plants, Animals, Food and Feed,
   Whereas:

               (1)

               Annex I to Regulation (EC) No 1099/2009 sets out the list of approved stunning methods, related specifications and the specific requirements for certain methods.

               (2)

               Annex II to Regulation (EC) No 1099/2009 sets out the requirements regarding the layout, construction and equipment of slaughterhouses.

               (3)

               Following a request from a private business operator the Commission requested the European Food Safety Authority (‘EFSA’) to provide an opinion on low atmospheric pressure system (‘the method’) for the stunning of broiler chickens (chickens kept for meat production).

               (4)

               In its opinion (2) of 25 October 2017, EFSA established that:

                           —

                           the method can be considered to be at least equivalent, in terms of animal welfare outcomes, to at least one of the currently available stunning methods,

                           —

                           the method is only valid under certain conditions and in particular: the technical specifications (as the rate of decompression, the duration of each phase and the total exposure time), the animal characteristics (broiler chickens) and certain ambient conditions (as temperature and humidity),

                           —

                           the assessment is limited only to broiler chickens for slaughter weighing up to 4 kg and its use cannot be extended to other category of birds;

               (5)

               In order to allow the competent authorities to perform regular checks on compliance with that method, specific requirements for that method should be laid down.

               (6)

               The method is considered, in addition to commercial slaughter, to be suitable for killing chickens in case of depopulation.

               (7)

               The method is also suitable in other cases where killing of high number of chickens is necessary for other reasons than public health, animal health, animal welfare or environmental reasons.

               (8)

               Considering that the method is equivalent, in terms of animal welfare outcomes, to at least one of the existing approved methods, it is therefore necessary to amend Annex I of Regulation (EC) No 1099/2009.

               (9)

               To enable the effective operation and monitoring of the method certain specific requirements regarding its layout, construction and equipment should be respected. It is therefore necessary to amend also Annex II to Regulation (EC) No 1099/2009.

               (10)

               Annexes I and II to Regulation (EC) No 1099/2009 should therefore be amended accordingly.

               (11)

               The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

         HAS ADOPTED THIS REGULATION:
   Article 1
   Regulation (EC) No 1099/2009 is amended as follows:

               (1)

               Annex I is amended as follows:

                           (a)

                           Table 3 of Chapter I is amended as follows:

                                       (i)

                                       the title is replaced by the following:
                                       ‘Table 3 — Controlled atmosphere methods’;

                                       (ii)

                                       the following row 7 is added:

                                                   No

                                                   Name

                                                   Description

                                                   Conditions of use

                                                   Key parameters

                                                   Specific requirements of Chapter II of this Annex

                                                   ‘7

                                                   Low atmospheric pressure stunning

                                                   Exposure of conscious animals to gradual decompression with reduction in available oxygen to less than 5 %.

                                                   Broiler chickens up to 4 kg live weight.
                                                   Slaughter, depopulation and other situations.

                                                   Rate of decompression.
                                                   Duration of exposure.
                                                   Ambient temperature and humidity.

                                                   Points 10.1 to 10.5’

                           (b)

                           in Chapter II, the following point 10 is added:
                           ‘10.   Low atmospheric pressure stunning

                           10.1.   During the first phase, the decompression rate shall not be greater than equivalent to a reduction in pressure from standard sea level atmospheric pressure 760 to 250 Torr for a period of not less than 50 seconds.
                           10.2.   During a second phase, a minimum standard sea level atmospheric pressure of 160 Torr shall be reached within the following 210 seconds.
                           10.3.   The pressure time curve shall be adjusted to ensure that all birds are irreversibly stunned within the cycle time.
                           10.4.   The chamber shall be leak tested and pressure gauges calibrated before each operational session and not less than daily.
                           10.5.   Records of absolute vacuum pressure, time of exposure, temperature and humidity shall be kept for at least one year.’;

               (2)

               in Annex II, the following point 7 is added:
               ‘7.   Low atmospheric pressure stunning

               7.1.   Low atmospheric pressure stunning equipment shall be designed and built to ensure a vacuum of the chamber enabling slow gradual decompression with reduction in available oxygen and holding at minimal pressure.
               7.2.   The system shall be equipped to measure continuously, display and record the absolute vacuum pressure, the time of exposure, the temperature, the humidity and to give a clearly visible and audible warning if the pressure deviates from the required levels. The device shall be clearly visible to the personnel.’.

         Article 2
   This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.

      This Regulation shall be binding in its entirety and directly applicable in all Member States.
      Done at Brussels, 16 May 2018.

            For the Commission

            The President

         Jean-Claude JUNCKER

      (1)  OJ L 303, 18.11.2009, p. 1.

      (2)  EFSA Journal 2017;15(12):5056.


title: Commission Implementing Regulation (EU) 2018/721 of 16 May 2018 amending Regulation (EU) No 37/2010 to classify the substance porcine prolactin as regards its maximum residue limit (Text with EEA relevance. )

text:
               17.5.2018

               EN

               Official Journal of the European Union

               L 122/5

         COMMISSION IMPLEMENTING REGULATION (EU) 2018/721
   of 16 May 2018
   amending Regulation (EU) No 37/2010 to classify the substance porcine prolactin as regards its maximum residue limit
   (Text with EEA relevance)
   THE EUROPEAN COMMISSION,
   Having regard to the Treaty on the Functioning of the European Union,
   Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and the Council (1), and in particular Article 14 in conjunction with Article 17 thereof,
   Having regard to the opinion of the European Medicines Agency (‘EMA’) formulated by the Committee for Medicinal Products for Veterinary Use,
   Whereas:

               (1)

               Article 17 of Regulation (EC) No 470/2009 requires that the maximum residue limit (‘MRL’) for pharmacologically active substances intended for use in the Union in veterinary medicinal products for food-producing animals or in biocidal products used in animal husbandry is established in a Regulation.

               (2)

               Table 1 of the Annex to Commission Regulation (EU) No 37/2010 (2) sets out the pharmacologically active substances and their classification regarding MRLs in foodstuffs of animal origin.

               (3)

               The substance porcine prolactin is not included in that table.

               (4)

               An application for the establishment of MRLs for porcine prolactin in porcine species has been submitted to EMA.

               (5)

               EMA, based on the opinion of the Committee for Medicinal Products for Veterinary Use, has recommended that the establishment of an MRL for porcine prolactin in porcine species is not necessary for the protection of human health.

               (6)

               According to Article 5 of Regulation (EC) No 470/2009, EMA is to consider using MRLs established for a pharmacologically active substance in a particular foodstuff for another foodstuff derived from the same species, or MRLs established for a pharmacologically active substance in one or more species for other species.

               (7)

               EMA has considered that the extrapolation of the ‘no MRL required’ classification for porcine prolactin from porcine species to other species is not appropriate at this time due to insufficient data.

               (8)

               Regulation (EU) No 37/2010 should therefore be amended accordingly.

               (9)

               The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

         HAS ADOPTED THIS REGULATION:
   Article 1
   The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
   Article 2
   This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

      This Regulation shall be binding in its entirety and directly applicable in all Member States.
      Done at Brussels, 16 May 2018.

            For the Commission

            The President

         Jean-Claude JUNCKER

      (1)  OJ L 152, 16.6.2009, p. 11.

      (2)  Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010, p. 1).

      ANNEX
      In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order:

                     Pharmacologically active Substance

                     Marker residue

                     Animal Species

                     MRL

                     Target Tissues

                     Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

                     Therapeutic Classification

                     ‘Porcine prolactin

                     NOT APPLICABLE

                     Porcine

                     No MRL required

                     NOT APPLICABLE

                     For oral use in newborn piglets at a dose of up to 0,2 mg/animal.
                     For use in sows at a total dose of up to 5 mg/animal.

                     Agents acting on the reproductive system’


title: Commission Implementing Regulation (EU) 2018/722 of 16 May 2018 amending Regulation (EU) No 37/2010 to classify the substance eprinomectin as regards its maximum residue limit (Text with EEA relevance. )

text:
               17.5.2018

               EN

               Official Journal of the European Union

               L 122/8

         COMMISSION IMPLEMENTING REGULATION (EU) 2018/722
   of 16 May 2018
   amending Regulation (EU) No 37/2010 to classify the substance eprinomectin as regards its maximum residue limit
   (Text with EEA relevance)
   THE EUROPEAN COMMISSION,
   Having regard to the Treaty on the Functioning of the European Union,
   Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and the Council (1), and in particular Article 14 in conjunction with Article 17 thereof,
   Having regard to the opinion of the European Medicines Agency (‘EMA’) formulated by the Committee for Medicinal Products for Veterinary Use,
   Whereas:

               (1)

               Article 17 of Regulation (EC) No 470/2009 requires that the maximum residue limit (‘MRL’) for pharmacologically active substances intended for use in the Union in veterinary medicinal products for food-producing animals or in biocidal products used in animal husbandry is established in a Regulation.

               (2)

               Table 1 of the Annex to Commission Regulation (EU) No 37/2010 (2) sets out the pharmacologically active substances and their classification regarding MRLs in foodstuffs of animal origin.

               (3)

               Eprinomectin is already included in that table as an allowed substance for all ruminants, applicable to muscle, fat, liver, kidney and milk.

               (4)

               An application for the extension of the existing entry for eprinomectin to fin fish has been submitted to EMA.

               (5)

               EMA, based on the opinion of the Committee for Medicinal Products for Veterinary Use, has recommended the establishment of an MRL for eprinomectin in fin fish.

               (6)

               According to Article 5 of Regulation (EC) No 470/2009, EMA is to consider using MRLs established for a pharmacologically active substance in a particular foodstuff for another foodstuff derived from the same species, or MRLs established for a pharmacologically active substance in one or more species for other species.

               (7)

               EMA has considered that the extrapolation of the entry for eprinomectin to the tissues of horses and rabbits is appropriate.

               (8)

               Regulation (EU) No 37/2010 should therefore be amended accordingly.

               (9)

               It is appropriate to grant the stakeholders concerned a reasonable period of time to take measures that may be required to comply with the new MRL.

               (10)

               The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

         HAS ADOPTED THIS REGULATION:
   Article 1
   The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
   Article 2
   This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
   It shall apply from 16 July 2018.

      This Regulation shall be binding in its entirety and directly applicable in all Member States.
      Done at Brussels, 16 May 2018.

            For the Commission

            The President

         Jean-Claude JUNCKER

      (1)  OJ L 152, 16.6.2009, p. 11.

      (2)  Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010, p. 1).

      ANNEX
      In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘eprinomectin’ is replaced by the following:

                     Pharmacologically active Substance

                     Marker residue

                     Animal Species

                     MRLs

                     Target Tissues

                     Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

                     Therapeutic Classification

                     ‘Eprinomectin

                     Eprinomectin B1a

                     All ruminants, equidae

                     50 μg/kg

                     Muscle

                     NO ENTRY

                     Antiparasitic agents/Agents acting against endo- and ectoparasites’

                     250 μg/kg

                     Fat

                     1 500  μg/kg

                     Liver

                     300 μg/kg

                     Kidney

                     20 μg/kg

                     Milk

                     Fin fish

                     50 μg/kg

                     Muscle and skin in natural proportions

                     Rabbits

                     50 μg/kg

                     Muscle

                     250 μg/kg

                     Fat

                     1 500  μg/kg

                     Liver

                     300 μg/kg

                     Kidney